|
|
Volumn 325, Issue 7374, 2002, Pages 1228-
|
|
Valvar heart disease and prosthetic heart valves
a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
FIBRINOLYTIC AGENT;
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
DIPYRIDAMOLE;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
PHYTOMENADIONE;
WARFARIN;
BALLOON DILATATION;
HEART VALVE PROSTHESIS;
HUMAN;
METHODOLOGY;
PROSTHESIS;
REVIEW;
THROMBOSIS;
VALVULAR HEART DISEASE;
ALGORITHM;
ANTICOAGULATION;
BIOPROSTHESIS;
BJOERK SHILEY VALVE PROSTHESIS;
BLEEDING;
DISEASE SEVERITY;
DOSE CALCULATION;
DRUG CHOICE;
DRUG CONTRAINDICATION;
EMBOLISM;
FIBRINOLYTIC THERAPY;
HANCOCK VALVE PROSTHESIS;
HIGH RISK PATIENT;
INTERNATIONAL STANDARD UNIT;
LONG TERM CARE;
PARTIAL THROMBOPLASTIN TIME;
POSTOPERATIVE CARE;
PRACTICE GUIDELINE;
PREGNANCY COMPLICATION;
PRIORITY JOURNAL;
RISK FACTOR;
SINUS RHYTHM;
STARR EDWARDS VALVE PROSTHESIS;
THROMBOGENICITY;
THROMBOPLASTIN TIME;
THROMBOSIS PREVENTION;
TREATMENT INDICATION;
VALVULOPLASTY;
ANTICOAGULANTS;
BALLOON DILATATION;
FIBRINOLYTIC AGENTS;
HEART VALVE DISEASES;
HEART VALVE PROSTHESIS;
HUMANS;
PROSTHESIS DESIGN;
THROMBOSIS;
|
|
EID: 0037164257
PISSN: 09598138
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.325.7374.1228 Document Type: Article |
|
Times cited : (32)
|
|
References (0)
|